Albert Labs International Company Description

Albert Labs International Corp., a biopharmaceutical drug discovery company, researches and develops drugs for psychedelic-assisted therapy for patients with urgent and unmet needs in Canada and the United Kingdom.

It develops KRN-101, is a solution for cancer-related anxiety. The company is based in Burnaby, Canada.

Albert Labs International Corp.

Country	Canada
Industry	Biotechnology
Sector	Healthcare
CEO	Navchand Jagpal

Contact Details

Address: 201-6996 Merritt Avenue Burnaby, V5J 4R6 Canada
Phone	778-819-0740
Website	albertlabs.com

Stock Details

Ticker Symbol	ABRT
Exchange	Canadian Securities Exchange
Fiscal Year	January - December
Reporting Currency	CAD
ISIN Number	CA0127841041
SIC Code	2836

Key Executives

Name	Position
Navchand Jagpal	Chief Executive Officer
Navchand Jagpal	Chief Financial Officer
Santoke Naal	Chief Operating Officer